The government, as a holder of shares in Pliva, requests the new owner to keep the company's seat and production plants in Zagreb, keep the existing labour and guarantee that the company would keep its leader status in the regional pharmaceutical industry.
If those requirements are met, the government will consider conditions for negotiations on selling its shares to the new owner created, the statement said.
Pliva reported today that its supervisory board had recommended to its shareholders to accept an offer by the US company Barr Pharmaceuticals for the purchase of the company's entire issued capital at a price of 705 kuna per share.